Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hildesheim

Showing results (81-90 of 360) with videos related to

Pageof 36
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus typesPhilip E Castle, Mark Schiffman, Robert D Burk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18Long Fu Xi, Laura A Koutsky, Allan Hildesheim, et al.
Vaccine|November 26, 2008
Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the CaribbeanEduardo L Franco, Vivien Tsu, Rolando Herrero, et al.
Journal of Medical Virology|August 24, 2017
Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinomaAnna E Coghill, Cheng-Ping Wang, Sandra A W M Verkuijilen, et al.
Clinical and Vaccine Immunology : CVI|June 29, 2007
Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particlesAlfonso García-Piñeres, Allan Hildesheim, Lori Dodd, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2021
Reproducibility, Temporal Variability, and Concordance of Serum and Fecal Bile Acids and Short Chain Fatty Acids in a Population-Based StudyZeinab Farhat, Joshua N Sampson, Allan Hildesheim, et al.
Journal of Clinical Immunology|April 18, 2002
Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levelsPhilip E Castle, Allan Hildesheim, Fredrick P Bowman, et al.
JAMA Oncology|October 19, 2023
Cancers Attributable to Infections in the US in 2017: A Meta-AnalysisKarena D Volesky-Avellaneda, Samantha Morais, Stephen D Walter, et al.
Journal of the National Cancer Institute|November 25, 2010
Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortMahboobeh Safaeian, Koen Quint, Mark Schiffman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 19, 2010
Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 yearsPaula González, Allan Hildesheim, Ana Cecilia Rodríguez, et al.
Pageof 36

Showing results (81-90 of 360) with videos related to

Sort By:
Pageof 36
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus typesPhilip E Castle, Mark Schiffman, Robert D Burk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18Long Fu Xi, Laura A Koutsky, Allan Hildesheim, et al.
Vaccine|November 26, 2008
Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the CaribbeanEduardo L Franco, Vivien Tsu, Rolando Herrero, et al.
Journal of Medical Virology|August 24, 2017
Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinomaAnna E Coghill, Cheng-Ping Wang, Sandra A W M Verkuijilen, et al.
Clinical and Vaccine Immunology : CVI|June 29, 2007
Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particlesAlfonso García-Piñeres, Allan Hildesheim, Lori Dodd, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2021
Reproducibility, Temporal Variability, and Concordance of Serum and Fecal Bile Acids and Short Chain Fatty Acids in a Population-Based StudyZeinab Farhat, Joshua N Sampson, Allan Hildesheim, et al.
Journal of Clinical Immunology|April 18, 2002
Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levelsPhilip E Castle, Allan Hildesheim, Fredrick P Bowman, et al.
JAMA Oncology|October 19, 2023
Cancers Attributable to Infections in the US in 2017: A Meta-AnalysisKarena D Volesky-Avellaneda, Samantha Morais, Stephen D Walter, et al.
Journal of the National Cancer Institute|November 25, 2010
Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortMahboobeh Safaeian, Koen Quint, Mark Schiffman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 19, 2010
Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 yearsPaula González, Allan Hildesheim, Ana Cecilia Rodríguez, et al.
Pageof 36